Short- and Long-Term Complications of Bronchopulmonary Dysplasia

References

1. 1.↵
   1. Trittmann JK,
   2. Nelin LD,
   3. Klebanoff MA

   . Bronchopulmonary dysplasia and neurodevelopmental outcome in extremely preterm neonates. Eur J Pediatr 2013;172(9):1173-1180.

   OpenUrlCrossRefPubMed
2. 2.↵
   1. Northway WH Jr.,
   2. Rosan RC,
   3. Porter DY

   . Pulmonary disease following respirator therapy of hyaline-membrane disease: bronchopulmonary dysplasia. N Engl J Med 1967;276(7):357-368.

   OpenUrlCrossRefPubMedWeb of Science
3. 3.↵
   1. Bancalari E,
   2. Abdenour GE,
   3. Feller R,
   4. Gannon J

   . Bronchopulmonary dysplasia: clinical presentation. J Pediatr 1979;95(5 Pt 2):819-823.

   OpenUrlCrossRefPubMedWeb of Science
4. 4.↵
   1. Tooley WH

   . Epidemiology of bronchopulmonary dysplasia. J Pediatr 1979;95(5 Pt 2):851-858.

   OpenUrlCrossRefPubMedWeb of Science
5. 5.↵
   1. Shennan AT,
   2. Dunn MS,
   3. Ohlsson A,
   4. Lennox K,
   5. Hoskins EM

   . Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period. Pediatrics 1988;82(4):527-532.

   OpenUrlAbstract/FREE Full Text
6. 6.↵
   1. Ehrenkranz RA,
   2. Walsh MC,
   3. Vohr BR,
   4. et al

   . Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia. Pediatrics 2005;116(6):1353-1360.

   OpenUrlAbstract/FREE Full Text
7. 7.↵
   1. Jobe AH,
   2. Bancalari E

   . Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001;163(7):1723-1729.

   OpenUrlCrossRefPubMed
8. 8.↵
   1. Walsh MC,
   2. Szefler S,
   3. Davis J,
   4. et al

   . Summary proceedings from the bronchopulmonary dysplasia group. Pediatrics 2006;117(Supplement 1):S52-S56.

   OpenUrlPubMedWeb of Science
9. 9.↵
   1. Baraldi E,
   2. Filippone M

   . Chronic lung disease after premature birth. N Engl J Med 2007;357(19):1946-1955.

   OpenUrlCrossRefPubMedWeb of Science
10. 10.↵
    1. Davidson LM,
    2. Berkelhamer SK

    . Bronchopulmonary dysplasia: chronic lung disease of infancy and long-term pulmonary outcomes. J Clin Med 2017;6(1).
11. 11.↵
    1. Siffel C,
    2. Kistler KD,
    3. Lewis JFM,
    4. Sarda SP

    . Global incidence of bronchopulmonary dysplasia among extremely preterm infants: a systematic literature review. J Matern Fetal Neonatal Med 2019:1-11.
12. 12.↵
    1. Jo HS,
    2. Cho KH,
    3. Cho S-I,
    4. Song ES,
    5. Kim BI

    . Recent changes in the incidence of bronchopulmonary dysplasia among very-low-birthweight infants in Korea. J Korean Med Sci 2015;30 Suppl 1:S81-87.

    OpenUrl
13. 13.↵
    1. Alvarez-Fuente M,
    2. Arruza L,
    3. Muro M

    , et al. The economic impact of prematurity and bronchopulmonary dysplasia. Eur J Pediatr 2017;176(12):1587-1593.

    OpenUrlPubMed
14. 14.↵
    1. Pasha AB,
    2. Chen XQ,
    3. Zhou GP

    . Bronchopulmonary dysplasia: pathogenesis and treatment. Exp Ther Med 2018;16(6):4315-4321.

    OpenUrl
15. 15.↵
    1. Zysman-Colman Z,
    2. Tremblay GM,
    3. Bandeali S,
    4. Landry JS

    . Bronchopulmonary dysplasia - trends over 3 decades. Paediatr Child Health 2013;18(2):86-90.

    OpenUrlCrossRefPubMedWeb of Science
16. 16.↵
    1. Thebaud B,
    2. Goss KN,
    3. Laughon M,
    4. et al

    . Bronchopulmonary dysplasia. Nat Rev Dis Primers 2019;5(1):78.

    OpenUrl
17. 17.↵
    1. Kim CJ,
    2. Romero R,
    3. Chaemsaithong P,
    4. Chaiyasit N,
    5. Yoon BH,
    6. Kim YM

    . Acute chorioamnionitis and funisitis: definition, pathologic features, and clinical significance. Am J Obstet Gynecol 2015;213(4 Suppl):S29-52.

    OpenUrlCrossRefPubMed
18. 18.↵
    1. Goldenberg RL,
    2. Andrews WW,
    3. Goepfert AR,
    4. et al.

    The Alabama preterm birth study: umbilical cord blood Ureaplasma urealyticum and Mycoplasma hominis cultures in very preterm newborn infants. Am J Obstet Gynecol 2008;198(1):43.e1-5-43.e5.

    OpenUrl
19. 19.↵
    1. Kallapur SG,
    2. Presicce P,
    3. Rueda CM,
    4. Jobe AH,
    5. Chougnet CA

    . Fetal immune response to chorioamnionitis. Semin Reprod Med 2014;32(1):56-67.

    OpenUrlCrossRefPubMed
20. 20.↵
    1. Savran O,
    2. Ulrik CS

    . Early-life insults as determinants of chronic obstructive pulmonary disease in adult life. Int J Chron Obstruct Pulmon Dis 2018;13:683-693.

    OpenUrl
21. 21.↵
    1. Kalikkot Thekkeveedu R,
    2. Guaman MC,
    3. Shivanna B

    . Bronchopulmonary dysplasia: a review of pathogenesis and pathophysiology. Respir Med 2017;132:170-177.

    OpenUrlCrossRefPubMed
22. 22.↵
    1. Aukland SM,
    2. Rosendahl K,
    3. Owens CM,
    4. Fosse KR,
    5. Eide GE,
    6. Halvorsen T

    . Neonatal bronchopulmonary dysplasia predicts abnormal pulmonary HRCT scans in long-term survivors of extreme preterm birth. Thorax 2009;64(5):405-410.

    OpenUrlAbstract/FREE Full Text
23. 23.↵
    1. Wong PM,
    2. Lees AN,
    3. Louw J,
    4. et al

    . Emphysema in young adult survivors of moderate-to severe bronchopulmonary dysplasia. Eur Respir J 2008;32(2):321-328.

    OpenUrlAbstract/FREE Full Text
24. 24.↵
    1. Whitsett JA,
    2. Wert SE,
    3. Weaver TE

    . Diseases of pulmonary surfactant homeostasis. Annu Rev Pathol 2015;10:371-393.

    OpenUrlCrossRefPubMed
25. 25.↵
    1. Principi N,
    2. Di Pietro GM,
    3. Esposito S

    . Bronchopulmonary dysplasia: clinical aspects and preventive and therapeutic strategies. J Transl Med 2018;16(1):36.

    OpenUrlCrossRefPubMed
26. 26.↵
    1. Townsi N,
    2. Laing IA,
    3. Hall GL,
    4. Simpson SJ

    . The impact of respiratory viruses on lung health after preterm birth. Eur Clin Respir J 2018;5(1):1487214.

    OpenUrl
27. 27.↵
    1. Scalco JC,
    2. Coelho R,
    3. Mucha FC,
    4. Schivinski CIS

    . Impact of bronchopulmonary dysplasia on pulmonary function during childhood: a systematic review. J Hum Growth Dev 2017;27(1):109-116.

    OpenUrl
28. 28.↵
    1. Tepper RS,
    2. Morgan WJ,
    3. Cota K,
    4. Taussig LM

    . Expiratory flow limitation in infants with bronchopulmonary dysplasia. J Pediatr 1986;109(6):1040-1046.

    OpenUrlCrossRefPubMedWeb of Science
29. 29.↵
    1. Groothuis JR,
    2. Gutierrez KM,
    3. Lauer BA

    . Respiratory syncytial virus infection in children with bronchopulmonary dysplasia. Pediatrics 1988;82(2):199-203.

    OpenUrlAbstract/FREE Full Text
30. 30.↵
    1. Liese JG,
    2. Grill E,
    3. Fischer B,
    4. Roeckl-Wiedmann I,
    5. Carr D,
    6. Belohradsky BH

    ; Munich RSV Study Group. Incidence and risk factors of respiratory syncytial virus-related hospitalizations in premature infants in Germany. Eur J Pediatr 2003;162(4):230-236.

    OpenUrlPubMedWeb of Science
31. 31.↵
    1. Acuña-Cordero R,
    2. Sossa-Briceño MP,
    3. Rodríguez-Martínez CE

    . Predictors of hospitalization for acute lower respiratory infections during the first two years of life in a population of preterm infants with bronchopulmonary dysplasia. Early Hum Dev 2018;127:53-57.

    OpenUrl
32. 32.↵
    1. Resch B,
    2. Gusenleitner W,
    3. Mandl C,
    4. Müller W

    . Epidemiology of respiratory syncytial virus infection in Southern Austria. Pediatr Infect Dis J 2000;19:587-588.

    OpenUrlPubMedWeb of Science
33. 33.
    1. Polin RA,
    2. Fox WW,
    3. Abmann SH

    1. Wert SE

    . Normal and abnormal structural development of the lung. In: Polin RA, Fox WW, Abmann SH, eds. 3rd ed. Fetal and Neonatal Physiology. Saunders; 2004:784-794.
34. 34.↵
    1. Ballow M,
    2. Cates KL,
    3. Rowe JC,
    4. Goetz C,
    5. Desbonnet C

    . Development of the immune system in very-low-birthweight (less than 1,500 g) premature infants: concentrations of plasma immunoglobulins and patterns of infections. Pediatr Res 1986;20(9):899-904.

    OpenUrlCrossRefPubMedWeb of Science
35. 35.↵
    1. Domm W,
    2. Misra RS,
    3. O'Reilly MA

    . Effect of early-life oxygen exposure on proper lung development and response to respiratory viral infections. Front Med (Lausanne) 2015;2:55.

    OpenUrl
36. 36.↵
    1. O'Reilly MA,
    2. Marr SH,
    3. Yee M,
    4. McGrath-Morrow SA,
    5. Lawrence BP

    . Neonatal hyperoxia enhances the inflammatory response in adult mice infected with influenza a virus. Am J Respir Crit Care Med 2008;177(10):1103-1110.

    OpenUrlCrossRefPubMedWeb of Science
37. 37.↵
    1. Powers CJ,
    2. Levitt MA,
    3. Tantoco J,
    4. et al

    . The respiratory advantage of laparoscopic Nissen fundoplication. J. Pediatr. Surg 2003;38(6):886-891.

    OpenUrlCrossRefPubMedWeb of Science
38. 38.↵
    1. Demirel G,
    2. Yilmaz Y,
    3. Uras N,
    4. et al

    . Dramatical recovery of a mechanical ventilatory-dependent extremely low birthweight premature infant after Nissen fundoplication. J Trop Pediatr 2011;57(6):484-486.

    OpenUrlCrossRefPubMed
39. 39.↵
    1. Akinola E,
    2. Rosenkrantz TS,
    3. Pappagallo M,
    4. McKay K,
    5. Hussain N

    . Gastroesophageal reflux in infants < 32 weeks gestational age at birth: lack of relationship to chronic lung disease. Am J Perinatol 2004;21(2):57-62.

    OpenUrlCrossRefPubMedWeb of Science
40. 40.↵
    1. Gien J,
    2. Kinsella J,
    3. Thrasher J,
    4. Grenolds A,
    5. Abman SH,
    6. Baker CD

    . Retrospective analysis of an interdisciplinary ventilator care program intervention on survival of infants with ventilator-dependent bronchopulmonary dysplasia. Am J Perinatol 2017;34(2):155-163.

    OpenUrl
41. 41.↵
    1. Hanin M,
    2. Nuthakki S,
    3. Malkar MB,
    4. Jadcherla SR

    . Safety and efficacy of oral feeding in infants with BPD on nasal CPAP. Dysphagia 2015;30(2):121-127. 241. 23582967.

    OpenUrlCrossRefPubMed
42. 42.↵
    1. Berkelhamer SK,
    2. Mestan KK,
    3. Steinhorn RH

    . Pulmonary hypertension in bronchopulmonary dysplasia. Semin Perinatol 2013;37(2):124-131.

    OpenUrlCrossRefPubMed
43. 43.↵
    1. An HS,
    2. Bae EJ,
    3. Kim GB,
    4. et al

    . Pulmonary hypertension in preterm infants with bronchopulmonary dysplasia. Korean Circ J 2010;40(3):131-136.

    OpenUrlCrossRefPubMed
44. 44.
    1. Bhat R,
    2. Salas AA,
    3. Foster C,
    4. Carlo WA,
    5. Ambalavanan N

    . Prospective analysis of pulmonary hypertension in extremely low birthweight infants. Pediatrics 2012;129(3):e682-689-e689.

    OpenUrl
45. 45.↵
    1. Mourani PM,
    2. Sontag MK,
    3. Younoszai A,
    4. et al

    . Early pulmonary vascular disease in preterm infants at risk for bronchopulmonary dysplasia. Am J Respir Crit Care Med 2015;191(1):87-95.

    OpenUrlCrossRefPubMed
46. 46.↵
    1. Steinhorn RH

    . Neonatal pulmonary hypertension. Pediatr Crit Care Med 2010;11(2 Suppl):S79-84.

    OpenUrlCrossRefPubMed
47. 47.↵
    1. Valencia AM,
    2. Abrantes MA,
    3. Hasan J,
    4. Aranda JV,
    5. Beharry KD

    . Reactive oxygen species, biomarkers of microvascular maturation and alveolarization, and antioxidants in oxidative lung injury. React Oxyg Species (Apex) 2018;6(18):373-388.

    OpenUrl
48. 48.↵
    1. Abman SH,
    2. Hansmann G,
    3. Archer SL,
    4. et al

    . American Heart Association Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation; Council on Clinical Cardiology; Council on Cardiovascular Disease in the Young; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Surgery and Anesthesia; and the American Thoracic Society. Pediatric pulmonary hypertension: guidelines from the American Heart Association and American Thoracic Society. Circulation 2015;132(21):2037-2099.

    OpenUrlAbstract/FREE Full Text
49. 49.↵
    1. Gisslen T,
    2. Hillman NH,
    3. Musk GC,
    4. et al

    . Repeated exposure to intra-amniotic LPS partially protects against adverse effects of intravenous LPS in preterm lambs. Innate Immun 2014;20(2):214-224.

    OpenUrlCrossRefPubMed
50. 50.↵
    1. Mourani PM,
    2. Mandell EW,
    3. Meier M,
    4. et al

    . Early pulmonary vascular disease in preterm infants is associated with late respiratory outcomes in childhood. Am J Respir Crit Care Med 2019;199(8):1020-1027.

    OpenUrlPubMed
51. 51.↵
    1. Khemani E,
    2. McElhinney DB,
    3. Rhein L,
    4. et al

    . Pulmonary artery hypertension in formerly premature infants with bronchopulmonary dysplasia: clinical features and outcomes in the surfactant era. Pediatrics 2007;120(6):1260-1269.

    OpenUrlAbstract/FREE Full Text
52. 52.↵
    1. Mourani PM,
    2. Abman SH

    . Pulmonary hypertension and vascular abnormalities in bronchopulmonary dysplasia. Clin Perinatol 2015;42(4):839-855.

    OpenUrlCrossRefPubMed
53. 53.↵
    1. Nakanishi H,
    2. Uchiyama A,
    3. Kusuda S

    . Impact of pulmonary hypertension on neurodevelopmental outcome in preterm infants with bronchopulmonary dysplasia: a cohort study. J Perinatol 2016;36(10):890-896.

    OpenUrlCrossRefPubMed
54. 54.↵
    1. Cardoen F,
    2. Vermeulen F,
    3. Proesmans M,
    4. Moens M,
    5. De Boeck K

    . Lung function evolution in children with old and new type bronchopulmonary dysplasia: a retrospective cohort analysis. Eur J Pediatr 2019;178(12):1859-1866.

    OpenUrl
55. 55.↵
    1. Smyth JA,
    2. Tabachnik E,
    3. Duncan WJ,
    4. Reilly BJ,
    5. Levison H

    . Pulmonary function and bronchial hyperreactivity in long-term survivors of bronchopulmonary dysplasia. Pediatrics 1981;68(3):336-340.

    OpenUrlAbstract/FREE Full Text
56. 56.↵
    1. Landry JS,
    2. Chan T,
    3. Lands L,
    4. Menzies D

    . Long-term impact of bronchopulmonary dysplasia on pulmonary function. Can Respir J 2011;18(5):265-270.

    OpenUrlCrossRefPubMed
57. 57.↵
    1. Farstad T,
    2. Brockmeier F,
    3. Bratlid D

    . Cardiopulmonary function in premature infants with bronchopulmonary dysplasia 2-year follow-up. Eur J Pediatr 1995;154(10):853-858.

    OpenUrlCrossRefPubMedWeb of Science
58. 58.↵
    1. May C,
    2. Kennedy C,
    3. Milner AD,
    4. Rafferty GF,
    5. Peacock JL,
    6. Greenough A

    . Lung function abnormalities in infants developing bronchopulmonary dysplasia. Arch Dis Child 2011;96(11):1014-1019.

    OpenUrlAbstract/FREE Full Text
59. 59.↵
    1. Northway WH Jr.,
    2. Moss RB,
    3. Carlisle KB,
    4. et al

    . Late pulmonary sequelae of bronchopulmonary dysplasia. N Engl J Med 1990;323(26):1793-1799.

    OpenUrlCrossRefPubMedWeb of Science
60. 60.↵
    1. Hacking DF,
    2. Gibson AM,
    3. Robertson C,
    4. Doyle LW

    ; Victorian Infant Collaborative Study Group (VICS). Respiratory function at age 8–9 after extremely low birthweight or preterm birth in Victoria in 1997. Pediatr Pulmonol 2013;48(5):449-455.

    OpenUrlCrossRefPubMed
61. 61.↵
    1. Balinotti JE,
    2. Chakr VC,
    3. Tiller C,
    4. et al

    . Growth of lung parenchyma in infants and toddlers with chronic lung disease of infancy. Am J Respir Crit Care Med 2010;181(10):1093-1097.

    OpenUrlCrossRefPubMedWeb of Science
62. 62.↵
    1. Narayanan M,
    2. Beardsmore CS,
    3. Owers-Bradley J,
    4. et al

    . Catch-up alveolarization in ex-preterm children: evidence from (3)He magnetic resonance. Am J Respir Crit Care Med 2013;187(10):1104-1109.

    OpenUrlCrossRefPubMedWeb of Science
63. 63.↵
    1. Joshi S,
    2. Powell T,
    3. Watkins WJ,
    4. Drayton M,
    5. Williams EM,
    6. Kotecha S

    . Exercise-induced bronchoconstriction in school-aged children who had chronic lung disease in infancy. J. Pediatr 2013;162(4):813-818.

    OpenUrlCrossRefPubMedWeb of Science
64. 64.↵
    1. Gough A,
    2. Linden M,
    3. Spence D,
    4. Patterson CC,
    5. Halliday HL,
    6. McGarvey LPA

    . Impaired lung function and health status in adult survivors of bronchopulmonary dysplasia. Eur Respir J 2014;43(3):808-816.

    OpenUrlAbstract/FREE Full Text
65. 65.↵
    1. Landry JS,
    2. Croitoru D,
    3. Jin Y,
    4. Schwartzman K,
    5. Benedetti A,
    6. Menzies D

    . Health care utilization by preterm infants with respiratory complications in Quebec. Can Respir J 2012;19(4):255-260.

    OpenUrlCrossRefPubMed
66. 66.↵
    1. El Mazloum D,
    2. Moschino L,
    3. Bozzetto S,
    4. Baraldi E

    . Chronic lung disease of prematurity: long-term respiratory outcome. Neonatology 2014;105(4):352-356.

    OpenUrlCrossRefPubMed
67. 67.↵
    1. Fakhoury KF,
    2. Sellers C,
    3. Smith EO,
    4. Rama JA,
    5. Fan LL

    . Serial measurements of lung function in a cohort of young children with bronchopulmonary dysplasia. Pediatrics 2010;125(6):e1441-7-e1447.

    OpenUrl
68. 68.↵
    1. Lodha A,
    2. Ediger K,
    3. Rabi Y,
    4. et al

    . Does chronic oxygen dependency in preterm infants with bronchopulmonary dysplasia at NICU discharge predict respiratory outcomes at 3 years of age? J Perinatol 2015;35(7):530-536.

    OpenUrlCrossRefPubMed
69. 69.↵
    1. Henningfeld JK,
    2. Maletta K,
    3. Ren B,
    4. Richards KL,
    5. Wegner C,
    6. D'Andrea LA

    . Liberation from home mechanical ventilation and decannulation in children. Pediatr Pulmonol 2016;51(8):838-849.

    OpenUrl
70. 70.↵
    1. Karila C,
    2. Saulnier J-P,
    3. Elie C,
    4. et al

    . Exercise alveolar hypoventilation in long-term survivors of bronchopulmonary dysplasia. Rev Mal Respir 2008;25(3):303-312.

    OpenUrlCrossRefPubMed
71. 71.↵
    1. Bates ML,
    2. Pillers DA,
    3. Palta M,
    4. Farrell ET,
    5. Eldridge MW

    . Ventilatory control in infants, children, and adults with bronchopulmonary dysplasia. Respir Physiol Neurobiol 2013;189(2):329-337.

    OpenUrl
72. 72.↵
    1. Rideau Batista Novais A,
    2. Matecki S,
    3. Jaussent A,
    4. et al

    . Hyperventilation during exercise in very low birthweight school-age children may implicate inspiratory muscle weakness. J Pediatr 2012;160(3):415-420.e1.

    OpenUrlPubMed
73. 73.↵
    1. Welsh L,
    2. Kirkby J,
    3. Lum S,
    4. et al

    ; EPICure Study Group. The EPICure study: maximal exercise and physical activity in school children born extremely preterm. Thorax 2010;65(2):165-172.

    OpenUrlAbstract/FREE Full Text
74. 74.↵
    1. Lovering AT,
    2. Elliott JE,
    3. Laurie SS,
    4. et al

    . Ventilatory and sensory responses in adult survivors of preterm birth and bronchopulmonary dysplasia with reduced exercise capacity. Ann Am Thorac Soc 2014;11(10):1528-1537.

    OpenUrlCrossRefPubMed
75. 75.↵
    1. Shi W,
    2. Warburton D

    . Is COPD in adulthood really so far removed from early development? Eur Respir J 2010;35(1):12-13.

    OpenUrlFREE Full Text
76. 76.↵
    1. Islam JY,
    2. Keller RL,
    3. Aschner JL,
    4. Hartert TV,
    5. Moore PE

    . Understanding the short- and long-term respiratory outcomes of prematurity and bronchopulmonary dysplasia. Am J Respir Crit Care Med 2015;192(2):134-156.

    OpenUrlCrossRefPubMed
77. 77.↵
    1. Barker DJ,
    2. Godfrey KM,
    3. Fall C,
    4. Osmond C,
    5. Winter PD,
    6. Shaheen SO

    . Relation of birthweight and childhood respiratory infection to adult lung function and death from chronic obstructive airways disease. BMJ 1991;303(6804):671-675.

    OpenUrlAbstract/FREE Full Text
78. 78.↵
    1. Van Durme YM,
    2. Eijgelsheim M,
    3. Joos GF,
    4. et al

    . Hedgehog-interacting protein is a COPD susceptibility gene: the Rotterdam study. Eur Respir J 2010;36(1):89-95.

    OpenUrlAbstract/FREE Full Text
79. 79.↵
    1. Doyle LW,
    2. Cheong JL,
    3. Burnett A,
    4. Roberts G,
    5. Lee KJ,
    6. Anderson PJ

    ; Victorian Infant Collaborative Study Group. Biological and social influences on outcomes of extreme-preterm/low-birthweight adolescents. Pediatrics 2015;136(6):e1513-20-e1520.

    OpenUrl
80. 80.↵
    1. Skidmore MD,
    2. Rivers A,
    3. Hack M

    . Increased risk of cerebral palsy among very low- birthweight infants with chronic lung disease. Dev Med Child Neurol 1990;32(4):325-332.

    OpenUrlPubMedWeb of Science
81. 81.↵
    1. Van Marter LJ,
    2. Kuban KC,
    3. Allred E,
    4. et al

    ; ELGAN Study Investigators. Does bronchopulmonary dysplasia contribute to the occurrence of cerebral palsy among infants born before 28 weeks of gestation? Arch Dis Child Fetal Neonatal Ed 2011;96(1):F20-9.

    OpenUrlAbstract/FREE Full Text
82. 82.↵
    1. Boel L,
    2. Pernet K,
    3. Toussaint M,
    4. et al

    . Respiratory morbidity in children with cerebral palsy: an overview. Dev Med Child Neurol 2019;61(6):646-653.

    OpenUrl
83. 83.↵
    1. Gray PH,
    2. O'Callaghan MJ,
    3. Rogers YM

    . Psychoeducational outcome at school age of preterm infants with bronchopulmonary dysplasia. J Paediatr Child Health 2004;40(3):114-120.

    OpenUrlCrossRefPubMedWeb of Science
84. 84.↵
    1. Lewis BA,
    2. Singer LT,
    3. Fulton S,
    4. et al

    . Speech and language outcomes of children with bronchopulmonary dysplasia. J Commun Disord 2002;35(5):393-406.

    OpenUrlCrossRefPubMedWeb of Science
85. 85.↵
    1. Majnemer A,
    2. Riley P,
    3. Shevell M,
    4. Birnbaum R,
    5. Greenstone H,
    6. Coates AL

    . Severe bronchopulmonary dysplasia increases risk for later neurological and motor sequelae in preterm survivors. Dev Med Child Neurol 2007;42(1):53-60.

    OpenUrl
86. 86.↵
    1. Arnaud C,
    2. Daubisse-Marliac L,
    3. White-Koning M,
    4. et al

    . Prevalence and associated factors of minor neuromotor dysfunctions at age 5 years in prematurely born children: the EPIPAGE study. Arch Pediatr Adolesc Med 2007;161(11):1053-1061.

    OpenUrlCrossRefPubMed
87. 87.↵
    1. Davis NM,
    2. Ford GW,
    3. Anderson PJ,
    4. Doyle LW

    ; Victorian Infant Collaborative Study Group. Developmental coordination disorder at 8 years of age in a regional cohort of extremely-low-birthweight or very preterm infants. Dev Med Child Neurol 2007;49(5):325-330.

    OpenUrlCrossRefPubMedWeb of Science
88. 88.↵
    1. Schmidt B,
    2. Asztalos EV,
    3. Roberts RS,
    4. Robertson CM,
    5. Sauve RS,
    6. Whitfield MF

    ; Trial of Indomethacin Prophylaxis in Preterms (TIPP) Investigators. Impact of bronchopulmonary dysplasia, brain injury, and severe retinopathy on the outcome of extremely low-birthweight infants at 18 months: results from the trial of indomethacin prophylaxis in preterms. JAMA 2003;289(9):1124-1129.

    OpenUrlCrossRefPubMedWeb of Science
89. 89.↵
    1. McGinnity FG,
    2. Halliday HL

    . Perinatal predictors of ocular morbidity in school children who were very low birthweight. Paediatr Perinat Epidemiol 1993;7(4):417-425.

    OpenUrlPubMed
90. 90.↵
    1. Gray PH,
    2. Sarkar S,
    3. Young J,
    4. Rogers YM

    . Conductive hearing loss in preterm infants with bronchopulmonary dysplasia. J Paediatr Child Health 2001;37(3):278-282.

    OpenUrlCrossRefPubMedWeb of Science
91. 91.↵
    1. Singer LT,
    2. Yamashita T,
    3. Lilien L,
    4. Collin M,
    5. Baley J

    . A longitudinal study of developmental outcome of infants with bronchopulmonary dysplasia and very low birthweight. Pediatrics 1997;100(6):987-993.

    OpenUrlAbstract/FREE Full Text
92. 92.↵
    1. Short EJ,
    2. Klein NK,
    3. Lewis BA,
    4. et al

    . Cognitive and academic consequences of bronchopulmonary dysplasia and very low birthweight: 8-year-old outcomes. Pediatrics 2003;112(5):e359-e359.

    OpenUrlAbstract/FREE Full Text
93. 93.↵
    1. Anderson PJ,
    2. Doyle LW

    . Neurodevelopmental outcome of bronchopulmonary dysplasia. Semin Perinatol 2006;30(4):227-232.

    OpenUrlCrossRefPubMedWeb of Science
94. 94.↵
    1. Farel AM,
    2. Hooper SR,
    3. Teplin SW,
    4. Henry MM,
    5. Kraybill EN

    . Very-low-birthweight infants at 7 years: an assessment of the health and neurodevelopmental risk conveyed by chronic lung disease. J Learn Disabil 1998;31(2):118-126.

    OpenUrlCrossRefPubMed
95. 95.↵
    1. Drummond D,
    2. Hadchouel A,
    3. Torchin H,
    4. et al

    ; EPIPAGEADO Study Group. Educational and health outcomes associated with bronchopulmonary dysplasia in 15-year-olds born preterm. PLoS ONE 2019;14(9):e0222286.

    OpenUrlCrossRef
96. 96.↵
    1. Brumbaugh JE,
    2. Bell EF,
    3. Grey SF,
    4. et al

    . Behavior profiles at 2 years for children born extremely preterm with bronchopulmonary dysplasia. J Pediatr 2020;219:152-159.e5.

    OpenUrl
97. 97.↵
    1. Taylor HG,
    2. Minich N,
    3. Bangert B,
    4. Filipek PA,
    5. Hack M

    . Long-term neuropsychological outcomes of very low birthweight: associations with early risks for periventricular brain insults. J Int Neuropsychol Soc 2004;10(7):987-1004.

    OpenUrlCrossRefPubMedWeb of Science
98. 98.↵
    1. Natarajan G,
    2. Pappas A,
    3. Shankaran S,
    4. et al

    . Outcomes of extremely low birthweight infants with bronchopulmonary dysplasia: impact of the physiologic definition. Early Hum Dev 2012;88(7):509-515.

    OpenUrlCrossRefPubMedWeb of Science
99. 99.↵
    1. Singer LT,
    2. Siegel AC,
    3. Lewis B,
    4. Hawkins S,
    5. Yamashita T,
    6. Baley J

    . Preschool language outcomes of children with history of bronchopulmonary dysplasia and very low birthweight. J Dev Behav Pediatr 2001;22:19-26.

    OpenUrlCrossRefPubMedWeb of Science
100. 100.↵
     1. Mowitz ME,
     2. Ayyagari R,
     3. Gao W,
     4. Zhao J,
     5. Mangili A,
     6. Sarda SP

     . Health care burden of bronchopulmonary dysplasia among extremely preterm infants. Front Pediatr 2019;7(510)
101. 101.↵
     1. Russell RB,
     2. Green NS,
     3. Steiner CA,
     4. et al

     . Cost of hospitalization for preterm and low-birthweight infants in the United States. Pediatrics 2007;120(1):e1-e9.

     OpenUrlAbstract/FREE Full Text
102. 102.↵
     1. Schmitt SK,
     2. Sneed L,
     3. Phibbs CS

     . Costs of newborn care in California: a population-based study. Pediatrics 2006;117(1):154-160.

     OpenUrlAbstract/FREE Full Text
103. 103.↵
     1. Smith VC,
     2. Zupancic JA,
     3. McCormick MC,
     4. et al

     . Rehospitalization in the first year of life among infants with bronchopulmonary dysplasia. J Pediatr 2004;144(6):799-803.

     OpenUrlPubMedWeb of Science
104. 104.↵
     1. Morrow CB,
     2. McGrath-Morrow SA,
     3. Collaco JM

     . Predictors of length of stay for initial hospitalization in infants with bronchopulmonary dysplasia. J Perinatol 2018;38(9):1258-1265.

     OpenUrl
105. 105.↵
     1. Langley GF,
     2. Anderson LJ

     . Epidemiology and prevention of respiratory syncytial virus infections among infants and young children. Pediatr Infect Dis J 2011;30(6):510-517.

     OpenUrlCrossRefPubMed
106. 106.↵
     1. Doyle LW,
     2. Anderson PJ

     . Long-term outcomes of bronchopulmonary dysplasia. Semin Fetal Neonatal Med 2009;14(6):391-395.

     OpenUrlCrossRefPubMedWeb of Science
107. 107.↵
     1. Greenough A,
     2. Alexander J,
     3. Burgess S,
     4. et al

     . Preschool health care utilization related to home oxygen status. Arch Dis Child Fetal Neonatal Ed 2006;91(5):F337-F341.

     OpenUrlAbstract/FREE Full Text
108. 108.↵
     Centers for Disease Control and Prevention (CDC). Economic costs associated with mental retardation, cerebral palsy, hearing loss, and vision impairment–United States, 2003. MMWR Morb Mortal Wkly Rep. 2004;53(3):57-59.
109. 109.↵
     1. Huysman WA,
     2. De Ridder M,
     3. De Bruin NC,
     4. et al

     . Growth and body composition in preterm infants with bronchopulmonary dysplasia. Arch Dis Child Fetal Neonatal Ed 2003;88(1):F46-51.

     OpenUrlAbstract/FREE Full Text
110. 110.↵
     1. Kurzner SI,
     2. Garg M,
     3. Bautista DB,
     4. et al

     . Growth failure in infants with bronchopulmonary dysplasia: nutrition and elevated resting metabolic expenditure. Pediatrics 1988;81(3):379-384.

     OpenUrlAbstract/FREE Full Text
111. 111.↵
     1. Kurzner SI,
     2. Garg M,
     3. Bautista DB,
     4. Sargent CW,
     5. Bowman CM,
     6. Keens TG

     . Growth failure in bronchopulmonary dysplasia: elevated metabolic rates and pulmonary mechanics. J Pediatr 1988;112(1):73-80.

     OpenUrlCrossRefPubMedWeb of Science
112. 112.↵
     1. Ehrenkranz RA,
     2. Das A,
     3. Wrage LA,
     4. et al

     ; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Early nutrition mediates the influence of severity of illness on extremely LBW infants. Pediatr Res 2011;69(6):522-529.

     OpenUrlCrossRefPubMedWeb of Science
113. 113.↵
     1. deRegnier RA,
     2. Guilbert TW,
     3. Mills MM,
     4. Georgieff MK

     . Growth failure and altered body composition are established by 1 month of age in infants with bronchopulmonary dysplasia. J Nutr 1996;126(1):168-175.

     OpenUrlAbstract/FREE Full Text
114. 114.↵
     1. Poindexter BB,
     2. Martin CR

     . Impact of nutrition on bronchopulmonary dysplasia. Clin Perinatol 2015;42(4):797-806.

     OpenUrlCrossRefPubMed
115. 115.↵
     1. Brady JM,
     2. Zhang H,
     3. Kirpalani H,
     4. DeMauro SB

     . Living with severe bronchopulmonary dysplasia - parental views of their child’s quality of life. J Pediatr 2019;207:117-122.

     OpenUrl
116. 116.↵
     1. Kajantie E,
     2. Strang-Karlsson S,
     3. Hovi P,
     4. et al

     . Adults born at very low birthweight exercise less than their peers born at term. J Pediatr 2010;157(4):610-616, 616.

     OpenUrlCrossRefPubMedWeb of Science
117. 117.↵
     1. Landry JS,
     2. Tremblay GM,
     3. Li PZ,
     4. Wong C,
     5. Benedetti A,
     6. Taivassalo T

     . Lung function and bronchial hyperresponsiveness in adults born prematurely. A cohort study. Ann Am Thorac Soc 2016;13(1):17-24.

     OpenUrlCrossRefPubMed
118. 118.↵
     1. Bozzetto S,
     2. Carraro S,
     3. Tomasi L,
     4. Berardi M,
     5. Zanconato S,
     6. Baraldi E

     . Health-related quality of life in adolescent survivors of bronchopulmonary dysplasia. Respirology 2016;21(6):1113-1117.

     OpenUrl
119. 119.↵
     1. McEvoy CT,
     2. Jain L,
     3. Schmidt B,
     4. Abman S,
     5. Bancalari E,
     6. Aschner JL

     . Bronchopulmonary dysplasia: NHLBI workshop on the primary prevention of chronic lung diseases. Ann Am Thorac Soc 2014;11(Suppl 3):S146-153.

     OpenUrlCrossRefPubMed
120. 120.↵
     1. Shepherd EG,
     2. De Luca D

     . New imaging tools allow bronchopulmonary dysplasia to enter the age of precision medicine. Am J Respir Crit Care Med 2020;202(7):924-926.

     OpenUrl